CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma.
Junyu TongWen JiangXiaoying ZhangRu WangTingting QiaoYingchun SongDingwei GaoXiaqing YuZhongwei LvDan LiPublished in: The Journal of international medical research (2022)
CCL22 and CCL26 could serve as prognostic biomarkers in thyroid carcinoma.